Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug–Drug Interaction Between Clopidogrel and Dasabuvir

Dasabuvir, a nonnucleoside NS5B polymerase inhibitor, is a sensitive substrate of cytochrome P450 (CYP) 2C8 with a potential for drug–drug interaction (DDI) with clopidogrel. A physiologically based pharmacokinetic (PBPK) model was developed for dasabuvir to evaluate the DDI potential with clopidogr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Pharmacol Ther
Main Authors: Shebley, M, Fu, W, Badri, P, Bow, DAJ, Fischer, V
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599937/
https://ncbi.nlm.nih.gov/pubmed/28411400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.689
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki